CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer
2023 · European Journal of Cell Biology · 13 citations
https://doi.org/10.1016/j.ejcb.2023.151299
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
230
Citations
9
h-index
9
i10-index
Amirali Hariri is an academic researcher from Isfahan University of Medical Sciences. The author has contributed to research in topics: Endometriosis Research and Treatment & Toxin Mechanisms and Immunotoxins & Synthesis and biological activity. The author has an h-index of 9, co-authored 19 publications.
ORCID: 0000-0001-5810-4353Click to start Chat